225 related articles for article (PubMed ID: 21516274)
1. Evaluation of β-tricalcium phosphate in human infrabony periodontal osseous defects: a clinical study.
Chawla K; Lamba AK; Faraz F; Tandon S
Quintessence Int; 2011 Apr; 42(4):291-300. PubMed ID: 21516274
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of relative efficacy of β-tricalcium phosphate with and without type I resorbable collagen membrane in periodontal infrabony defects: a clinical and radiographic study.
Kishore DT; Bandiwadekar T; Padma R; Debunath S; Profulla ; Reddy A
J Contemp Dent Pract; 2013 Mar; 14(2):193-201. PubMed ID: 23811645
[TBL] [Abstract][Full Text] [Related]
3. Effect of platelet-rich plasma on the healing of intrabony defects treated with Beta tricalcium phosphate and expanded polytetrafluoroethylene membranes.
Döri F; Huszár T; Nikolidakis D; Tihanyi D; Horváth A; Arweiler NB; Gera I; Sculean A
J Periodontol; 2008 Apr; 79(4):660-9. PubMed ID: 18380559
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of a biphasic calcium composite grafting material in the treatment of human periodontal intrabony defects: a 12-month randomized controlled clinical trial.
Stein JM; Fickl S; Yekta SS; Hoischen U; Ocklenburg C; Smeets R
J Periodontol; 2009 Nov; 80(11):1774-82. PubMed ID: 19905932
[TBL] [Abstract][Full Text] [Related]
5. Randomized controlled clinical study of rhPDGF-BB + β-TCP versus HA + β-TCP for the treatment of infrabony periodontal defects: clinical and radiographic results.
Thakare K; Deo V
Int J Periodontics Restorative Dent; 2012 Dec; 32(6):689-96. PubMed ID: 23057058
[TBL] [Abstract][Full Text] [Related]
6. A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: a 12-month re-entry study.
Froum SJ; Weinberg MA; Rosenberg E; Tarnow D
J Periodontol; 2001 Jan; 72(1):25-34. PubMed ID: 11210070
[TBL] [Abstract][Full Text] [Related]
7. Comparison of bioactive glass synthetic bone graft particles and open debridement in the treatment of human periodontal defects. A clinical study.
Froum SJ; Weinberg MA; Tarnow D
J Periodontol; 1998 Jun; 69(6):698-709. PubMed ID: 9660339
[TBL] [Abstract][Full Text] [Related]
8. Ten-year results following treatment of intrabony defects with an enamel matrix protein derivative combined with either a natural bone mineral or a β-tricalcium phosphate.
Döri F; Arweiler NB; Szántó E; Agics A; Gera I; Sculean A
J Periodontol; 2013 Jun; 84(6):749-57. PubMed ID: 22873657
[TBL] [Abstract][Full Text] [Related]
9. Human histologic and clinical evaluation of recombinant human platelet-derived growth factor and beta-tricalcium phosphate for the treatment of periodontal intraosseous defects.
Ridgway HK; Mellonig JT; Cochran DL
Int J Periodontics Restorative Dent; 2008 Apr; 28(2):171-9. PubMed ID: 18546813
[TBL] [Abstract][Full Text] [Related]
10. Surgical treatment of periodontal intrabony defects with calcium sulfate implant and barrier versus collagen barrier or open flap debridement alone: a 12-month randomized controlled clinical trial.
Paolantonio M; Perinetti G; Dolci M; Perfetti G; Tetè S; Sammartino G; Femminella B; Graziani F
J Periodontol; 2008 Oct; 79(10):1886-93. PubMed ID: 18834243
[TBL] [Abstract][Full Text] [Related]
11. Five-year results of a prospective, randomized, controlled study evaluating treatment of intra-bony defects with a natural bone mineral and GTR.
Sculean A; Schwarz F; Chiantella GC; Donos N; Arweiler NB; Brecx M; Becker J
J Clin Periodontol; 2007 Jan; 34(1):72-7. PubMed ID: 17243997
[TBL] [Abstract][Full Text] [Related]
12. A phase IIa randomized controlled pilot study evaluating the safety and clinical outcomes following the use of rhGDF-5/β-TCP in regenerative periodontal therapy.
Windisch P; Stavropoulos A; Molnár B; Szendröi-Kiss D; Szilágyi E; Rosta P; Horváth A; Capsius B; Wikesjö UM; Sculean A
Clin Oral Investig; 2012 Aug; 16(4):1181-9. PubMed ID: 21887500
[TBL] [Abstract][Full Text] [Related]
13. Effects of pretreatment clinical parameters on bioactive glass implantation in intrabony periodontal defects.
Park JS; Suh JJ; Choi SH; Moon IS; Cho KS; Kim CK; Chai JK
J Periodontol; 2001 Jun; 72(6):730-40. PubMed ID: 11453234
[TBL] [Abstract][Full Text] [Related]
14. Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: results of a large multicenter randomized controlled trial.
Nevins M; Giannobile WV; McGuire MK; Kao RT; Mellonig JT; Hinrichs JE; McAllister BS; Murphy KS; McClain PK; Nevins ML; Paquette DW; Han TJ; Reddy MS; Lavin PT; Genco RJ; Lynch SE
J Periodontol; 2005 Dec; 76(12):2205-15. PubMed ID: 16332231
[TBL] [Abstract][Full Text] [Related]
15. Volumetric analysis of intrabony defects in aggressive periodontitis patients following use of a novel composite alloplast: a pilot study.
Kumar PG; Kumar JA; Anumala N; Reddy KP; Avula H; Hussain SN
Quintessence Int; 2011 May; 42(5):375-84. PubMed ID: 21519556
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the relative efficacy of autologous platelet-rich plasma in combination with β-tricalcium phosphate alloplast versus an alloplast alone in the treatment of human periodontal infrabony defects: a clinical and radiological study.
Saini N; Sikri P; Gupta H
Indian J Dent Res; 2011; 22(1):107-15. PubMed ID: 21525688
[TBL] [Abstract][Full Text] [Related]
17. Assessment of combination techniques in enhancing the regenerative potential of tricalcium phosphate graft in treatment of infrabony periodontal defects.
Saini A; Singh M; Lal N; Dixit J
Indian J Dent Res; 2011; 22(3):391-5. PubMed ID: 22048577
[TBL] [Abstract][Full Text] [Related]
18. Stem Cells Cultured on Beta Tricalcium Phosphate (β-TCP) in Combination with Recombinant Human Platelet-Derived Growth Factor - BB (rh-PDGF-BB) for the Treatment of Human Infrabony Defects.
Dhote R; Charde P; Bhongade M; Rao J
J Stem Cells; 2015; 10(4):243-54. PubMed ID: 27144828
[TBL] [Abstract][Full Text] [Related]
19. Four-year results following treatment of intrabony periodontal defects with an enamel matrix derivative alone or combined with a biphasic calcium phosphate.
Pietruska M; Pietruski J; Nagy K; Brecx M; Arweiler NB; Sculean A
Clin Oral Investig; 2012 Aug; 16(4):1191-7. PubMed ID: 21881869
[TBL] [Abstract][Full Text] [Related]
20. Hydroxyapatite cement implant for regeneration of periodontal osseous defects in humans.
Brown GD; Mealey BL; Nummikoski PV; Bifano SL; Waldrop TC
J Periodontol; 1998 Feb; 69(2):146-57. PubMed ID: 9526913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
